Intrinsiqq
Demant A/S logo

Demant A/S Quality Score

DEMANT.XCSE

⊜ Compare
Quality68

Growth remains strong (avg 85/100), but valuation is pulling the composite down (avg 50/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
52.8x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
60/100
27.2x

25–30x, paying up for cash generation

Revenue Growth
70/100
5.2%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
100/100
20.8%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
100/100
-3.9%

Shrinking >2%, active buybacks

Margin Trend
90/100
+1.4pp

Expanded 1–3pp, steady progress

Capital Structure
0/100
kr 19.66B

Net debt/FCF of 6.6x, high leverage

2022
kr 1.13B
kr 15.1B
2023
kr 1.14B
kr 14.4B
2024
kr 1.11B
kr 15.7B
2025
kr 1.33B
kr 21.0B
CashDebt
Return on Capital
60/100
10.7%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Demant A/S (DEMANT.XCSE) quality: score, margins and returns

Demant A/S (DEMANT.XCSE) scores 68/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 17.1% operating margins and 10.7% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Demant A/S (DEMANT.XCSE) a high-quality business?+

Demant A/S scores 68 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 17.1% operating margin and a 10.7% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Demant A/S's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from DEMANT.XCSE's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Demant A/S scores well and where it falls behind.

What is Demant A/S's return on invested capital (ROIC)?+

Demant A/S earns about 10.7% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to DEMANT.XCSE's margins and growth on this scorecard to judge durability.

How profitable is Demant A/S?+

Demant A/S runs an operating margin of about 17.1% and a net margin of about 6.7%. Revenue has grown at roughly 6.4% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on DEMANT.XCSE: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Peers

Medical Devices · Pick stocks to compare with DEMANT.XCSE

CompareIntrinsic value
GN.XCSEGN Store Nord A/S
No recent price3
BAVA.XCSEBavarian Nordic A/S
€33.22+1.47%84
GUBRA.XCSEGubra A/S
€40.96+4.76%98
SHL.XETRSiemens Healthineers AG
€44.85+3.46%65
CAP.XPARCapgemini SE
€129.50+3.43%39
FMSFresenius Medical Care AG - Depositary Receipt
$23.19+6.72%58
ATT.XSTOAttendo AB
kr 115.40+3.54%75
PHGKoninklijke Philips N.V. ADR
$31.06+9.14%44

Held by ETFs

DEMANT.XCSE is in 37 US ETFs. The largest of them, with DEMANT.XCSE's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DEMANT.XCSE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.